Clinical study offer

🧠 Paid Schizophrenia Clinical Trials

Browse recruiting schizophrenia clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Schizophrenia
Condition

Active Clinical Trials for Schizophrenia

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Schizophrenia

Schizophrenia is a severe mental disorder affecting thoughts, emotions, and behavior, characterized by psychosis and cognitive impairment. Clinical trials investigate novel antipsychotics, cognitive remediation therapies, and early intervention strategies.

Common Symptoms

Hallucinations, delusions, disorganized thinking, reduced emotional expression, social withdrawal, cognitive deficits, lack of motivation, unusual movements

Risk Factors

Family history, genetic factors, birth complications, prenatal infection or malnutrition, stress, substance use (especially cannabis), older paternal age

Treatment Overview

Treatment includes antipsychotic medications, psychosocial interventions, cognitive behavioral therapy, coordinated specialty care, and vocational support. Clinical trials explore trace amine-associated receptor agonists, muscarinic receptor modulators, and cognitive training interventions.

Why Participate?

Schizophrenia clinical trials are essential for developing treatments that address negative symptoms and cognitive deficits with better tolerability.

Related Conditions

States with Schizophrenia Clinical Trials

Cities with Schizophrenia Clinical Trials

Frequently Asked Questions About Schizophrenia Clinical Trials

Schizophrenia clinical trials test new antipsychotic medications and therapeutic interventions to reduce symptoms and improve daily functioning. Studies explore novel drug mechanisms that may offer better efficacy with fewer side effects.
Eligibility requires a schizophrenia diagnosis confirmed by psychiatric evaluation. Factors include symptom severity, illness duration, and prior treatment responses.
Compensation varies. Participants typically receive $50-$200 per visit with study medications and psychiatric monitoring provided at no cost.
Yes, participants receive regular psychiatric assessments and medical monitoring. All trials have safety oversight and ethical review board approval.